1Kadakia RA,Ferguson JJ.Optimal antithrombotic treatment for percutaneous coronary intervention.Minerva Cardioangiol,2005,53:15-42.
2Smith SC Jr,Dove JT,Jacobs AK,et al.ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary:a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions.Circulation,2001,103:3019-3041.
3Longstreth KL,Wertz JR.High-dose clopidogrel loading in percutaneous coronary intervention.Ann Pharmacother,2005,39:918-922.
4Williams SG,Wright DJ,Tan LB.Management of cardiogenic shock complicating acute myocardial infarction:towards evidence based medical practice.Heart,2000,83:621-626.
5Liuzzo JP,Shin YT,Choi C,et al.Simultaneous papillary muscle avulsion and free wall rupture during acute myocardial infarction.Intra-aortic balloon pump:a bridge to survival.J Invasive Cardiol,2006,18:135-140.
6Santa-Cruz RA,Cohen MG,Ohman EM.Aortic counterpulsation:a review of the hemodynamic effects and indications for use.Catheter Cardiovasc Interv,2006,67:68-77.
7Mehta SR,Yusuf S,Peters RJ,et al.Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention:the PCI-CURE study.Lancet,2001,358:527-533.
5Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angi- na/non ST - elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [ J ]. Circulation ,2007,116 (7) :148 -304.
